Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

317 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Quality of life in patients with acute myelogenous leukemia in prolonged first complete remission after bone marrow transplantation (allogeneic or autologous) or chemotherapy: a cross-sectional study of the EORTC-GIMEMA AML 8A trial.
Zittoun R, Suciu S, Watson M, Solbu G, Muus P, Mandelli F, Stryckmans P, Peetermans M, Thaler J, Resegotti L, Dardenne M, Willemze R. Zittoun R, et al. Among authors: suciu s. Bone Marrow Transplant. 1997 Aug;20(4):307-15. doi: 10.1038/sj.bmt.1700888. Bone Marrow Transplant. 1997. PMID: 9285546
Prognostic factors of patients with acute myeloid leukemia (AML) allografted in first complete remission: an analysis of the EORTC-GIMEMA AML 8A trial. The European Organization for Research and Treatment of Cancer (EORTC) and the Gruppo Italiano Malattie Ematologiche Maligne dell' Adulto (GIMEMA) Leukemia Cooperative Groups.
Keating S, Suciu S, de Witte T, Mandelli F, Willemze R, Resegotti L, Broccia G, Thaler J, Labar B, Damasio E, Bizzi B, Rotoli B, Vekhoff A, Muus P, Petti MC, Dardenne M, Solbu G, Vegna ML, Zittoun RA. Keating S, et al. Among authors: suciu s. Bone Marrow Transplant. 1996 Jun;17(6):993-1001. Bone Marrow Transplant. 1996. PMID: 8807105 Clinical Trial.
High numbers of mobilized CD34+ cells collected in AML in first remission are associated with high relapse risk irrespective of treatment with autologous peripheral blood SCT or autologous BMT.
Hengeveld M, Suciu S, Chelgoum Y, Marie JP, Muus P, Lefrère F, Mandelli F, Pane F, Amadori S, Fioritoni G, Labar B, Baron F, Cermak J, Bourhis JH, Storti G, Fazi P, Hagemeijer A, Vignetti M, Willemze R, de Witte T. Hengeveld M, et al. Among authors: suciu s. Bone Marrow Transplant. 2015 Mar;50(3):341-7. doi: 10.1038/bmt.2014.262. Epub 2014 Nov 17. Bone Marrow Transplant. 2015. PMID: 25402418 Free article. Clinical Trial.
A randomized comparison of intensive maintenance treatment for adult acute myelogenous leukemia using either cyclic alternating drugs or repeated courses of the induction-type chemotherapy: AML-6 trial of the EORTC Leukemia Cooperative Group.
Jehn U, Zittoun R, Suciu S, Fiere D, Haanen C, Peetermans M, Löwenberg B, Willemze R, Solbu G, Stryckmans P. Jehn U, et al. Among authors: suciu s. Haematol Blood Transfus. 1990;33:277-84. doi: 10.1007/978-3-642-74643-7_50. Haematol Blood Transfus. 1990. PMID: 1691132 Clinical Trial.
EORTC Leukemia Group trials on acute myeloid leukemias: an overview.
Hayat M, Zittoun R, Strychmans P, Löwenberg B, Solbu G, Suciu S. Hayat M, et al. Among authors: suciu s. Haematol Blood Transfus. 1990;33:271-6. doi: 10.1007/978-3-642-74643-7_49. Haematol Blood Transfus. 1990. PMID: 2182421 Clinical Trial. No abstract available.
317 results